Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07458087 · ClinicalTrials.gov registry record · NA
Accuracy of the Accuro 3S
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07458087 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 50 participants.
The verdict
NCT07458087, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate the feasibility and accuracy of the Accuro 3S to provide live guidance when performing a neuraxial technique (e.g., spinal, or epidural). The Accuro 3S is a new device that was designed to allow for midline live neuraxial guidance. If the device can perform as the manufacturers claim the device will permit the performance of epidurals as close as doing them under fluoroscopy.
Interventions
- DEVICE ACCURO 3S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2028-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07458087
The ClinicalTrials.gov registry entry for NCT07458087 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACCURO 3S is the first listed.
NCT07458087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07458087 about?
NCT07458087 is a clinical study titled "Accuracy of the Accuro 3S". The main purpose of this study is to evaluate the feasibility and accuracy of the Accuro 3S to provide live guidance when performing a neuraxial technique (e.g., spinal, or epidural). The Accuro 3S is a new device that was designed to allow for midline live neuraxial guidance. If the device can per...
What is the current status of trial NCT07458087?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-15. Estimated completion is 2028-01-15.
What interventions are being tested in trial NCT07458087?
The interventions under investigation include: ACCURO 3S (DEVICE).
Who is sponsoring clinical trial NCT07458087?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.